Learn more about breast cancer screening and the importance of mammograms, featuring Dr. Anupama Acheson from Providence Cancer Institute.
Patients with hormone-receptor-positive, HER2-positive metastatic breast cancer may qualify for a newly opened clinical trial at Providence Cancer...
Immunotherapy is a treatment approach that harnesses the immune system to recognize, attack and eliminate cancer.
The opportunity to conduct...
Providence Cancer Center is currently enrolling patients in more than 20 studies investigating a broad spectrum of breast cancer therapies and interventions.
More than 200,000 women in the U.S. are diagnosed with breast cancer each year. Early detection is still key to help improve outcomes and finish cancer.
Dense breast tissue is normal. Half of women have dense tissue, a higher percentage of glandular and fibrous tissue in their breasts.
For women in their peak childbearing years, a breast cancer diagnosis and subsequent treatments can create fertility, pregnancy and breastfeeding challenges.
The National Cancer Institute released a recent study which forecasts breast cancer cases will increase by 50 percent by 2030.
On Halloween, breast cancer patient Melissa Roy-Hart, aka Wonder Woman, allowed reporters to follow her to her final breast cancer treatment at Providence Cancer Center Oncology and Hematology Care Clinic – Southeast.